ARCHIVES

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

This article is from The Cancer Letter archive.

Vol. 15 No. 07 | February 17, 1989

Download PDF Visit The Full Archive

Related Articles

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

Group chairmen Advises 7 Trials For Priority Status

June 14, 1991

HHS bans tobacco from its campuses, opens national quitline, 1-800-QUITNOW.

November 19, 2004

Ten Is The New 12: Medicare Lowers Hemoglobin Targets For ESA Use.

August 3, 2007

Colon Polyps in Elderly Patients Are More Likely to Be Found Only with Colonoscopy

October 25, 2013

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993